Upadacitinib APIs by Loncom Pharma represent a new generation of Janus kinase inhibitors, providing relief for autoimmune conditions such as rheumatoid arthritis. These APIs offer a new hope for patients with moderate to severe cases, where other treatments may not have been effective.
| Name | Size | Update | Download |
|---|---|---|---|
| Biocom_Loncom FDF Product List.pdf | 2.03MB | 2026-08-20 | Download |
| Biocom_Loncom Intermediate Product List.pdf | 804KB | 2026-08-20 | Download |
| Biocom_Loncom API Product List.pdf | 1.78MB | 2026-08-20 | Download |
